Drugs / High Dose Inactivated Influenza Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01654224 Comparator | Nov 2011 → Jun 2014 | influenza | University of Pittsburgh | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | High Dose Inactivated Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01654224 ↗ |
| Known as | HDIV | “For HDIV,0.5 ml of high dose inactivated influenza vaccine consisting of a total of 180mcg (60 mcg each strain) of influenza virus hemagglutinin” NCT01654224 ↗ |
| Modality | Vaccine | “high dose inactivated influenza vaccine” NCT01654224 ↗ |